Register an account to search through 14,000+ stocks!
Ad
Company Profile
Vyne Therapeutics Inc. is a specialty pharmaceutical company. The Company is engaged in developing proprietary and differentiated therapies for the treatment of immuno-inflammatory conditions and rare skin diseases with high unmet medical need. The Company’s proprietary pipeline FMX114, which is a potential treatment of mild-to-moderate atopic dermatitis in patients 12 years of age and older, and access to a library of bromodomain and extra-terminal (BET) domain inhibitors in both topical and oral forms for the potential treatment of major immuno-inflammatory conditions and rare skin diseases.
Ad
Business
PASS
Vyne Therapeutics Inc has cleared the Business screen. Its business activity is compliant with the Shariah standard. If you find this result mistaken or questionable, let us know in the comments.
Impure: N/A
—
Recommendation Rating
2
1
2
3
4
5
Analysts’ Price Targets
Mean 5.8
Low: 6
High: 10
Total Analysts: 6
Financials
PASS
The financials pass just one standard and fail in the other two.
FTSE
Debt / Assets
35.39%
Cash / Assets
61.41%
(Cash + AR) / Assets
61.41%
✘
✘
✘
AAOIFI
Debt / Market cap
100%
Non-Compliant Assets
0%
✘
✔
DJIM
Debt / 24MC
16.63%
Cash / 24MC
28.85%
AR / 24MC
0%
✔
✔
—
Fundamentals
Market cap
Assets
Revenue Growth
Div./Share
$30457044
$93742000
—
—
✘ FTSE
✘ AAOIFI
✔ DJIM
We do our best to screen stocks as accurately as possible. Please let us know in the comments if you spot an error or find something questionable. Jazaak Allahu khairan.
Ad
Responses